Close

Rating History for Sage Therapeutics (SAGE) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for SAGE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/3/2023 Yatin Suneja Downgrade Neutral
(Buy)		 N/A
(N/A)		 38.67
(13.33)		 -65.53% Details